Lapatinib and Paclitaxel in Treating Patients With Advanced Solid Tumors
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Bladder Cancer|Brain and Central Nervous System Tumors|Breast Cancer|Esophageal Cancer|Extragonadal Germ Cell Tumor|Gastric Cancer|Lung Cancer|Ovarian Cancer|Prostate Cancer
Interventions: DRUG: lapatinib|DRUG: paclitaxel
Sponsor: University of California, San Francisco
Collaborators: National Cancer Institute (NCI)